Detalles de la búsqueda
1.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122385
2.
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
Haematologica
; 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38899352
3.
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.
Haematologica
; 107(1): 221-230, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33327711
4.
Dactinomycin in acute myeloid leukemia with NPM1 mutations.
Eur J Haematol
; 105(3): 302-307, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452083
5.
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
BMC Cancer
; 19(1): 883, 2019 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488077
6.
Dermatological toxicities induced by T-cell-redirecting G protein-coupled receptor family C class 5 member D bispecific antibody talquetamab.
J Am Acad Dermatol
; 90(2): 376-377, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742842
7.
Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey.
Haematologica
; 103(12): 2040-2048, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30006448
8.
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Am J Hematol
; 90(11): 986-91, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26214580
9.
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.
Am J Hematol
; 90(9): 811-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26094614
10.
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biol Blood Marrow Transplant
; 20(9): 1349-55, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24838178
11.
Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Haematologica
; 104(4): e154-e157, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309852
12.
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.
Haematologica
; 99(1): 46-53, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975179
13.
Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network.
Am J Hematol
; 89(12): E244-52, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25195872
14.
Phthalate contamination in marine mammals off the Norwegian coast.
Mar Pollut Bull
; 199: 115936, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38154171
15.
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.
Clin Cancer Res
; 29(1): 134-142, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36318706
16.
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.
Eur J Cancer
; 191: 112984, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549532
17.
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood Adv
; 7(21): 6589-6598, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672383
18.
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Leukemia
; 37(7): 1521-1529, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316728
19.
The impact of physician's characteristics on decision-making inhead and neck oncology: Results of a national survey.
Oral Oncol
; 129: 105895, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35500434
20.
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Leuk Lymphoma
; 63(6): 1398-1406, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35634787